![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/20 | |
A61K 38/12 | |||
A61P 3/10 |
(11) | Number of the document | 3443979 |
(13) | Kind of document | T |
(96) | European patent application number | 18179669.9 |
Date of filing the European patent application | 2012-03-09 | |
(97) | Date of publication of the European application | 2019-02-20 |
(45) | Date of publication and mention of the grant of the patent | 2020-05-27 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
11305269 | 2011-03-11 | EP | |
201161451663 P | 2011-03-11 | US |
(72) |
KLATZMANN, David, FR
SAADOUN, David, FR
CACOUB, Patrice, FR
ROSENZWAJG, Michčle, FR
PIAGGIO, Eliane, FR
BENSIMON, Gilbert, FR
BERNARD, Claude, FR
|
(73) |
INSERM (Institut National de la Santé et de la Recherche Médicale),
101, rue de Tolbiac, 75013 Paris,
FR
Sorbonne Université, 21, rue de L`École de Médecine, 75006 Paris, FR ASSISTANCE PUBLIQUE - H PITAUX DE PARIS, 3, avenue Victoria, 75004 Paris, FR |
(54) | IL-2 DOSAGE REGIMEN FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS |
IL-2 DOSAGE REGIMEN FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS |